Related Experiment Video
Updated: Mar 11, 2026

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
10.0K
Delineation of cortical pathology in multiple sclerosis using multi-surface magnetization transfer ratio imaging
David A Rudko1, Mishkin Derakhshan2, Josefina Maranzano1
1McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Neuroimage. Clinical
|November 23, 2016
Summary
Cortical surface magnetization transfer ratio (csMTR) measurements reveal sub-pial demyelination in multiple sclerosis (MS) patients. These csMTR reductions correlate with clinical disability, highlighting their potential as biomarkers for MS brain pathology.
Area of Science:
- Neuroimaging
- Biomarkers
- Multiple Sclerosis Research
Background:
- Multiple sclerosis (MS) involves cortical gray matter pathology.
- Sub-pial demyelination is a key feature of MS.
- Developing accessible biomarkers for cortical changes is crucial.
Purpose of the Study:
- To assess cortical surface magnetization transfer ratio (csMTR) on inner, mid, and outer cortical boundaries.
- To evaluate csMTR as a biomarker for cortical gray matter pathology in MS.
- To investigate the relationship between csMTR and clinical disability in MS patients.
Main Methods:
- Acquired 3 Tesla MRI anatomical and MTR images from 25 MS patients and 12 controls.
- Smoothed MTR maps along meshes representing inner, mid, and outer neocortical boundaries.
- Utilized mixed model analysis and age regression to evaluate csMTR reductions.
Main Results:
- Focal csMTR reductions were most prominent on the outer cortical surface in specific brain regions.
- MS patients showed age-dependent csMTR reductions, with some reaching a plateau.
- The difference in csMTR between inner and outer cortex correlated with clinical disability in MS patients.
Conclusions:
- Multi-surface analysis of csMTR is a sensitive marker for cortical sub-pial abnormalities in MS.
- csMTR measurements can serve as clinically accessible biomarkers for MS brain pathology.
- These findings advance understanding of MS-related cortical changes and their clinical relevance.

